GB201008210D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201008210D0 GB201008210D0 GBGB1008210.5A GB201008210A GB201008210D0 GB 201008210 D0 GB201008210 D0 GB 201008210D0 GB 201008210 A GB201008210 A GB 201008210A GB 201008210 D0 GB201008210 D0 GB 201008210D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1008210.5A GB201008210D0 (en) | 2010-05-17 | 2010-05-17 | Compounds |
KR1020127030829A KR20130109936A (en) | 2010-05-17 | 2011-05-16 | Compounds |
AU2011254668A AU2011254668A1 (en) | 2010-05-17 | 2011-05-16 | Compounds |
PCT/EP2011/057900 WO2011144577A1 (en) | 2010-05-17 | 2011-05-16 | Compounds |
EP11721742A EP2571856A1 (en) | 2010-05-17 | 2011-05-16 | Compounds |
CA2799556A CA2799556A1 (en) | 2010-05-17 | 2011-05-16 | Compounds |
JP2013510586A JP2013526555A (en) | 2010-05-17 | 2011-05-16 | Compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1008210.5A GB201008210D0 (en) | 2010-05-17 | 2010-05-17 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201008210D0 true GB201008210D0 (en) | 2010-06-30 |
Family
ID=42334886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1008210.5A Ceased GB201008210D0 (en) | 2010-05-17 | 2010-05-17 | Compounds |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2571856A1 (en) |
JP (1) | JP2013526555A (en) |
KR (1) | KR20130109936A (en) |
AU (1) | AU2011254668A1 (en) |
CA (1) | CA2799556A1 (en) |
GB (1) | GB201008210D0 (en) |
WO (1) | WO2011144577A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110330461A (en) * | 2019-06-13 | 2019-10-15 | 苏州莱安医药化学技术有限公司 | A kind of preparation method of 2- chloro-5-methoxyl pyrimidine |
CN110240601A (en) * | 2019-07-22 | 2019-09-17 | 湖北广富林生物制剂有限公司 | A kind of synthetic method of penoxsuam intermediate |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI70411C (en) * | 1980-12-29 | 1986-09-19 | Pfizer | FORM OF ANTHYPERTENSIVE 4-AMINO-6,7-DIMETOXY-2-PIPERAZINOQUINAZOLE DERIVATIVES |
EP1720847A1 (en) * | 2004-02-02 | 2006-11-15 | Pfizer Products Incorporated | Histamine-3 receptor modulators |
GB0608386D0 (en) | 2006-04-27 | 2006-06-07 | Senexis Ltd | Compounds |
-
2010
- 2010-05-17 GB GBGB1008210.5A patent/GB201008210D0/en not_active Ceased
-
2011
- 2011-05-16 CA CA2799556A patent/CA2799556A1/en not_active Abandoned
- 2011-05-16 KR KR1020127030829A patent/KR20130109936A/en not_active Application Discontinuation
- 2011-05-16 EP EP11721742A patent/EP2571856A1/en not_active Withdrawn
- 2011-05-16 JP JP2013510586A patent/JP2013526555A/en not_active Withdrawn
- 2011-05-16 WO PCT/EP2011/057900 patent/WO2011144577A1/en active Application Filing
- 2011-05-16 AU AU2011254668A patent/AU2011254668A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2799556A1 (en) | 2011-11-24 |
JP2013526555A (en) | 2013-06-24 |
AU2011254668A1 (en) | 2012-12-06 |
KR20130109936A (en) | 2013-10-08 |
WO2011144577A1 (en) | 2011-11-24 |
EP2571856A1 (en) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181788T1 (en) | Substituted pyridinone-pyridinyl compounds | |
IL223783A0 (en) | Pro-neurogenic compounds | |
GB201008134D0 (en) | Compounds | |
GB201015949D0 (en) | Compounds | |
HK1187908A1 (en) | Imidazotriazinone compounds | |
GB201020179D0 (en) | New compounds | |
GB201007286D0 (en) | New compounds | |
AP2012006641A0 (en) | New compounds | |
GB201007347D0 (en) | Compounds | |
EP2605658A4 (en) | Spiroxazolidinone compounds | |
EP2649050A4 (en) | Compounds | |
GB201002563D0 (en) | Compounds | |
GB201008209D0 (en) | Compounds | |
GB201001688D0 (en) | Compounds | |
GB201002216D0 (en) | Compounds | |
GB201015537D0 (en) | Compounds | |
GB201008210D0 (en) | Compounds | |
GB201001796D0 (en) | Compounds | |
GB201021494D0 (en) | Compounds | |
GB201022042D0 (en) | Compounds | |
GB201019227D0 (en) | Compounds | |
GB201015757D0 (en) | Compounds | |
GB201015145D0 (en) | Compounds | |
GB201014392D0 (en) | Compounds | |
GB201014052D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |